1-9 of 9
Gregory Maglinte
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-world treatment patterns and patient characteristics of venetoclax combination time-limited therapy for chronic lymphocytic leukemia

Free
Jing-Zhou Hou, Rushir Choksi, Gregory Maglinte, Xiaoliang Wang, Anna Rui, Beverly Chigarira, Lindsay Aton, Melissa Hagan, Lisa Morere, Mike Gart, Rhys Williams, Daniel Ermann
Journal: Blood
Blood (2025) 146 (Supplement 1): 6317.
https://doi.org/10.1182/blood-2025-6317
Published: 2025
Journal Articles

Impact of testing for genetic markers on treatment selection and clinical outcomes among patients with chronic lymphocytic leukemia

Free
Brian Koffman, Xiaoliang Wang, Qianhong Fu, Dong Yuan, Derrick van Beuge, Gregory Maglinte, Erlene Seymour
Journal: Blood
Blood (2025) 146 (Supplement 1): 3894.
https://doi.org/10.1182/blood-2025-3894
Published: 2025
Journal Articles

Real-world chronic lymphocytic leukemia/small lymphocytic lymphoma treatment patterns at Florida cancer specialists & research institute among patients receiving zanubrutinib immediately following prior BTKi therapy

Free
Amanda Warner, Xiaoliang Wang, Ashley Hernandez, Christian Okitondo, Karen Carr, Gregory Maglinte, Judah Friedman
Journal: Blood
Blood (2025) 146 (Supplement 1): 8062.
https://doi.org/10.1182/blood-2025-8062
Published: 2025
Journal Articles

Real-world chronic lymphocytic leukemia (CLL)–specific biomarker testing patterns and frontline treatment patterns in patients with CLL/small lymphocytic lymphoma (SLL)

Free
Timothy Reynolds, William Ye, Linda Chen, Archana Sagar, Mohammad Eskandari, Xiaoliang Wang, Lee Ding, Gregory Maglinte, Paul Godley
Journal: Blood
Blood (2025) 146 (Supplement 1): 8077.
https://doi.org/10.1182/blood-2025-8077
Published: 2025
Journal Articles

Treatment patterns and outcomes among patients treated with second-generation BTK inhibitors in CLL

Free
Aryan Ayati, Xiaoliang Wang, Kanika Chandra, Qianhong Fu, Marjan Massoudi, Gregory Maglinte, Madhav Seshadri, Vivek Rudrapatna
Journal: Blood
Blood (2025) 146 (Supplement 1): 4528.
https://doi.org/10.1182/blood-2025-4528
Published: 2025
Journal Articles

Real-world zanubrutinib treatment patterns in CLL/SLL among a curated sample of US community oncology patients with prior acalabrutinib therapy

Free
Jing-Zhou Hou, Rushir Choksi, Gregory Maglinte, Xiaoliang Wang, Anna Rui, Beverly Chigarira, Lindsay Aton, Melissa Hagan, Lisa Morere, Rhys Williams, Daniel Ermann
Journal: Blood
Blood (2025) 146 (Supplement 1): 8041.
https://doi.org/10.1182/blood-2025-8041
Published: 2025
Journal Articles

Real-world treatment patterns and biomarker utilization among patients aged ≥65 years with CLL/SLL from 2020 to 2024

Free
Paul Hampel, Daniel Ermann, Xiaoliang Wang, Peter Kardel, Caitlin Sheetz, Ashis Das, Qianhong Fu, Lee Ding, Gregory Maglinte, Erlene Seymour, Ryan Jacobs
Journal: Blood
Blood (2025) 146 (Supplement 1): 2723.
https://doi.org/10.1182/blood-2025-2723
Published: 2025
Journal Articles

Mediators of racial and ethnic inequities in access to front-line therapies for chronic lymphocytic leukemia in the United States: A real-world evidence study

Free
Joanna Rhodes, Adam Kittai, Paul Hampel, Xiaoliang Wang, Qianhong Fu, Danni Zhao, Smriti Karwa, Olive Mbah, Ahmed Sawas, Benjamin Wagner, Rachel Myers, Derrick van Beuge, Gregory Maglinte, Erlene Seymour, Jacqueline Barrientos
Journal: Blood
Blood (2025) 146 (Supplement 1): 2720.
https://doi.org/10.1182/blood-2025-2720
Published: 2025
Journal Articles

Changes in real-world treatment patterns over time by patient characteristics and time burden of treatment in CLL/SLL

Free
Mengyang Di, Xiaoliang Wang, Qianhong Fu, Dong Yuan, Gregory Maglinte, Erlene Seymour, Joanna Rhodes
Journal: Blood
Blood (2025) 146 (Supplement 1): 6283.
https://doi.org/10.1182/blood-2025-6283
Published: 2025